Retrospective screening for heterogeneous vancomycin resistance in diverse Staphylococcus aureus clones disseminated in French hospitals

Journal of Antimicrobial Chemotherapy

Volumn 45, Issue 6, 2000, Pages 887-890

  Chesneau, O ^a   Morvan, A ^a   El Solh, N ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; POLYPEPTIDE ANTIBIOTIC AGENT; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; FRANCE; HOSPITAL INFECTION; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; SCREENING TEST; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

EID: 0034083041     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/45.6.887     Document Type: Article

References (10)

1. Hiramatsu, K. (1998). Vancomycin resistance in staphylococci. Drug Resistance Updates 1, 135-50.
2. Hiramatsu, K., Aritaka, N., Hanaki, H., Kawasaki, S., Hosoda, Y., Hori, S. et al. (1997). Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350, 1670-3.
3. Ploy, M. C., Grélaud, C., Martin, C., de Lumley, L. & Denis, F. (1998). First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital. Lancet 351, 1212.
4. Smith, T. L., Pearson, M. L., Wilcox, K. R., Cruz, C., Lancaster, M. V., Robinson-Dunn, B. et al. (1999). Emergence of vancomycin resistance in Staphylococcus aureus. New England Journal of Medicine 340, 493-501.
5. Patron, R. L., Climo, M. W., Goldstein, B. P. & Archer, G. L. (1999). Lysostaphin treatment of experimental aortic valve endocarditis caused by a Staphylococcus aureus isolate with reduced susceptibility to vancomycin. Antimicrobial Agents and Chemotherapy 43, 1754-5.
6. Geisel, R., Schmitz, F. J., Thomas, L., Berns, G., Zetsche, O., Ulrich, B. et al. (1999). Emergence of heterogeneous intermediate vancomycin resistance in Staphylococcus aureus isolates in the Düsseldorf area. Journal of Antimicrobial Chemotherapy 43, 846-8.
7. Tenover, F. C., Lancaster, M. V., Hill, B. C., Steward, C. D., Stocker, S. A., Hancock, G. A. et al. (1998). Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. Journal of Clinical Microbiology 36, 1020-7.
8. Morvan, A., Aubert, S., Godard, C. & El Solh, N. (1997). Contribution of a typing method based on IS256 probing of Smal-digested cellular DNA to discrimination of European phage type 77 methicillin-resistant Staphylococcus aureus strains. Journal of Clinical Microbiology 35, 1415-23.
9. Howe, R. A., Wootton, M., Bennett, P. M., MacGowan, A. P. & Walsh, T. R. (1999). Interactions between methicillin and vancomycin in methicillin-resistant Staphylococcus aureus strains displaying different phenotypes of vancomycin susceptibility. Journal of Clinical Microbiology 37, 3068-71.
10. Kantzanou, M., Tassios, P. T., Tseleni-Kotsovili, A., Legakis, N. J. & Vatopoulos, A. C. (1999). Reduced susceptibility to vancomycin of nosocomial isolates of methicillin-resistant Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 43, 729-31.